| Application no. and date | 06740942.5 (espacenet) (Federated) (European Patent Register), 20060411 | | Patent/reg. no. and date | DK/EP 1888103, 20120321 | | Publication date | 20080220 | | Priority no. and date | US 669876 P, 20050411 | | EP pub. no. and date |
EP 1888103 20080220 | | Effective date | | | Applicant/owner | Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US,
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike
Wilmington, DE 19850-5437, US | | Applicant ref. no. | P81201375DK00E | | Inventor | ANDERSON, Christen, Amylin Pharmac., Inc., 9360 Towne Centre Drive
San Diego,
California 92121, US,
LIU, Que, c/o Amylin Pharmac., Inc.,9360 Towne Centre Drive
San Diego,
California 92121, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/22 (2006.01) , A61K 38/26 (2006.01) , A61P 9/00 (2006.01) | | Title | ANVENDELSE AF GLP-1, EXENDIN OG AGONISTER DERAF TIL FORSINKELSE ELLER FORHINDRING AF KARDIAL REMODELLERING | | Int. application no. | US2006013949 | | Int. publication no. | WO2006110887 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
